Background Intercellular IgA dermatosis (IAD) is a subset of autoimmune bullous disease exclusively with IgA antikeratinocyte cell-surface antibodies. The classification and pathogenesis of this condition are still obscure. Objectives To classify IAD and study its pathogenesis. Methods From our cohort of 5402 cases of autoimmune bullous disease, we selected 49 cases of various types of intercellular IgA dermatosis (IAD) and 13 cases of classical subcorneal pustular dermatosis (SPD), for which sera and information were available. We studied these cases clinically and immunologically. Results There were 17 SPD-type IAD, 12 intraepidermal neutrophilic IgA dermatosis (IEN)-type IAD, two IgA-pemphigus vegetans, four IgA-pemphigus foliaceus, six IgApemphigus vulgaris and eight unclassified IAD cases. There was no sex predominance, and the average age at disease onset was 45Á9 years. Clinically, bullous and pustular skin lesions developed on various sites, particularly intertriginous areas. Histopathology showed intraepidermal blisters or pustules at the upper epidermis in the SPD-type and at the midepidermis in the IEN-type. Immunological studies revealed that direct immunofluorescence, indirect immunofluorescence of normal human skin and enzyme-linked immunosorbent assays (ELISAs) of recombinant proteins of desmogleins and desmocollins frequently showed positive results, although no antigens were detected in many cases. All cases of classical SPD, which showed no positive immunological results, were indistinguishable clinically and histopathologically from SPD-type IAD. Conclusions The present study of the largest cohort of cases of IAD showed that the major subtypes are SPD and IEN, and that the combination of indirect immunofluorescence and ELISAs of desmogleins and desmocollins, in addition to direct immunofluorescence, was useful for the diagnosis of IAD and its subtypes.
Pemphigus is an autoimmune bullous disease (AIBD) showing autoantibodies to molecules on keratinocyte cell-surfaces, including desmogleins (Dsgs) and desmocollins (Dscs). Two major types are pemphigus foliaceus (PF) and pemphigus vulgaris (PV), reactive with Dsg1 and Dsg3, respectively. [1] [2] [3] Another subset of pemphigus showing IgA anticell-surface antibodies is called intercellular IgA dermatosis (IAD) or IgA pemphigus. 4, 5 Because we consider that the term 'IAD' is more suitable for this condition, 5 we will use the term 'IAD' throughout this report. IAD is divided into two major subtypes, subcorneal pustular dermatosis (SPD)-type and intraepidermal neutrophilic IgA dermatosis (IEN)-type. 4, 5 Later, we
proposed the terms IgA-PF and IgA-PV, for subtypes showing IgA reactivity with Dsg1 and Dsg3, respectively. [5] [6] [7] We previously showed that Dsc1 is an autoantigen in the SPDtype by a cDNA transfection method. 8 However, cDNA transfection is difficult in terms of both procedures and assessments. 9 In addition, enzyme-linked immunosorbent assays (ELISAs) using baculovirus-produced recombinant proteins (RPs) failed to detect IgA anti-Dsc antibodies. 10 To overcome these problems, we established sensitive IgA ELISAs using mammalian Dsc RPs. 9, 11 As one of the centres for diagnosis of AIBDs in Japan, we have collected sera and information of more than 5000 difficult cases of various AIBDs over the last 20 years. 12 In this large cohort of AIBDs, many cases were suspected to be IAD. In this study, we clinically and immunologically characterized 49 cases of IAD and 13 cases of classical SPD, which were diagnosed by our tentative diagnostic criteria.
Materials and methods

Cases and sera
This study used our cohort of 5402 cases with various AIBDs, for which sera and information were sent from other institutes between May 1996 and December 2015. Thus, a limitation of this study is that the cases were collected only from a cohort of various AIBDs with difficulty in diagnoses and sent from other institutes. We have previously reported studies including relatively large numbers of cases used in this study. 4, 6, 8, [13] [14] [15] Other previous reports for cases used in this study are listed in Appendix S1 (see Supporting Information).
Immunofluorescence studies
Direct immunofluorescence (IF) for IgG, IgA, IgM and C3 using skin biopsies, and indirect IF of normal human skin and monkey oesophagus for both IgG and IgA antibodies were performed by standard methods. Indirect IF of 1 mol L
À1
NaCl-split normal human skin for IgG and IgA antibodies was performed as described previously. 16 Immunoblotting studies
We performed immunoblotting of normal human epidermal extract, 17, 18 22 and purified human laminin-332 23 for IgG antibodies, as described previously.
Enzyme-linked immunosorbent assays
We performed commercially available IgG ELISAs of Dsg1 and Dsg3 RPs (cut-off: index < 12) (MESACUP; MBL, Nagoya, Japan). 24 IgA ELISAs of Dsg1 and Dsg3 RPs (cut-off: optical density < 0Á15) were performed as described previously. 6 We also performed commercially available IgG ELISAs (MESACUP) of BP180 NC16a domain RP (cut-off: index < 15), 25 BP230 RPs (cut-off: index < 9) 26 and type VII collagen RP (cut-off: index < 15). 27 Optical density was measured with a microplate reader (Nalge Nunc International Co., New York, NY, U.S.A.).
Novel IgG and IgA enzyme-linked immunosorbent assays of mammalian recombinant proteins of human desmocollins 1-3
We performed novel ELISAs of mammalian RPs of human Dsc1-3 for both IgG 9 and IgA antibodies 11 (Appendix S2; see Supporting Information).
COS-7 cell cDNA transfection
COS-7 cell cDNA transfection for human Dsc1-3 was performed as described previously.
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Results
Diagnoses
By our tentative criteria, we made the final diagnoses of IAD and classical SPD in 49 and 13 cases, respectively ( Table 1) . The criteria also determined 17 cases of SPD-type IAD, 12 IEN-type IAD, eight unclassified IAD, two IgA-PVeg, four IgA-PF and six IgA-PV (Table 1) . One and three cases of IgA-PF were clinicopathologically diagnosed as IEN-type and unclassified IAD, respectively. Two, one and one of the cases of IgA-PV were clinicopathologically diagnosed as IEN-type, unclassified IAD and IgA-PVeg, respectively. Additionally, four diagnoses with multiple AIBDs were made (Table S1 ; see Supporting Information).
The consultation letters showed original suspicion of various clinical diagnoses for the 49 confirmed cases of IAD (Table S1 ; see Supporting Information). Regarding subtypes of IAD, the originally suspected clinical diagnoses in the consultation letters were SPD-type for eight cases, IEN-type for seven cases, IgA-PV for two cases and IgA-PVeg for one case (Table S1 ; see Supporting Information).
Next, these cases were characterized clinically and immunologically. Because of the large cohort size and long surveillance time for this study, some clinical findings and immunological results could not be obtained from all cases. Therefore, we analysed each parameter only for cases with information available.
Clinical findings in 49 cases of intercellular IgA dermatosis
Background of cases
Among the 49 cases of IAD, 29 were Japanese, while 12, four, three and one were from European countries, Brazil, the U.S.A. and South Korea, respectively. There were 20 each of male and female patients, with nine cases without sex information. The mean age of disease onset for the 49 cases was 45Á9 years (male, 45Á4 years; female, 46Á5 years). The duration of disease before our tests ranged from 1 week to 20 years (mean 39Á5 months).
Regarding underlying diseases, ulcerative colitis was associated with six cases of IAD, including two cases each of IEN-type, IgA-PV and unclassified cases, without SPD-type cases. Although IgA multiple myeloma was associated with only one case, elevated serum levels of IgA were found in three cases. Two cases had bullous pemphigoid and one case was pregnant. There were no other specific underlying diseases, including malignant tumours. We did not analyse the background for each subtype, because there were no significant differences.
Previous treatments were systemic steroids (13 cases), dapsone (four), antibiotics (four), sulfasalazine (three), immunosuppressants (three), antihistamines (three) and psoralen-ultraviolet A (one).
Clinical manifestations
From the data available in consultation letters for the 49 cases of IAD, involved sites were the whole body (10 cases), trunk (23; mainly back), extremities (21; mainly lower extremities), intertriginous areas (11; mainly axillae and inguinal areas) and head (six cases) ( Table 2 ). Oral mucosal lesions were found in three cases and genital and anal mucosal lesions were found in one case each, while six cases were reported to have no oral mucosal lesions (Fig. 1a,d,g ).
Clinical manifestations were blisters (39 cases), pustules (33), erythemas (19) , erosions (six) and vegetating lesions (three) ( Table 2) . Annular erythemas were reported in eight cases. Vesicles and small pustules were seen in 10 cases and Table 2) , with descriptions of annular erythemas (three) and vesicles (four). Itch was reported in one case.
Histopathological features
Among 37 cases of IAD with information, histopathology of skin biopsies showed intraepidermal lesions (26 cases) of either pustules (17) or blisters (three) at the upper epidermis (18) and the entire or middle epidermis (eight) ( Table 2 ).
Intraepidermal infiltrations of neutrophils, eosinophils and lymphocytes were found in 23, 11 and four cases, respectively, and acantholysis was present in 17 cases (Fig. 1b ,e,h; Table 2 ).
All 16 SPD-type cases with histopathological information showed intraepidermal lesions at the upper epidermis or subcorneal areas, while five of nine IEN-type cases were reported to show intraepidermal lesions at the whole or middle epidermis (Table 2) . One case of IgA-PV showed suprabasilar pustules. Unclassified cases showed intraepidermal pustules (five cases) and presence of acantholysis (six). In all IAD subtypes, infiltrating cells were mainly neutrophils, followed by eosinophils.
Treatments, responsiveness and complications
Dapsone was effective in seven cases, but not in four cases, whereas systemic steroids were effective in six cases, but not in four cases (Table S2 ; see Supporting Information). Regarding immunosuppressants, azathioprine was effective in one case, while ciclosporin A was ineffective in one case. Minocycline was effective in two cases, but not in one case.
Immunological findings in intercellular IgA dermatosis
Direct immunofluorescence
Results of direct IF were reported for IgA deposition in 35 cases of IAD, and less frequently for IgG, IgM and C3. For deposition to keratinocyte cell-surfaces, IgA was deposited in 29 (83%) of 35 cases, specifically at the upper (five), entire (seven) and lower (one) epidermis, while very weak IgG deposition was reported in one case. In addition, deposition to the epidermal BMZ was found for IgA (four cases), IgM (one) and C3 (three).
Indirect immunofluorescence
In indirect IF of normal human skin performed for 48 cases of IAD, 31 (65%) and two (4%) cases showed IgA and IgG (very weak) antikeratinocyte cell-surface antibodies, respectively (Fig. 1c,f,i) . In addition, six cases (12%) and one case (2%) showed IgG and IgA anti-BMZ antibodies, respectively (Table S3 ; see Supporting Information).
In indirect IF of monkey oesophagus, five (25%) of 20 cases showed IgA anticell-surface antibodies (Table S3 ; see Supporting Information). In indirect IF of 1 mol L À1 NaCl-split human skin for 18 cases, reactivity with the epidermal and dermal sides for IgG antibodies was found in four cases (22%) and one case (6%), while reactivity with the epidermal and dermal sides for IgA antibodies was found in two cases (11%) and one case (6%) ( Table S3 ; see Supporting Information).
Immunoblotting studies of various substrates
IgG immunoblotting of normal human epidermal extract performed for 46 cases of IAD detected IgG reactivity with BP230 in four cases (9%), with BP180 in two cases (4%) and Dsc in one case (2%). For IgA antibodies in 47 cases of IAD, BP230, Dsg3 and Dscs were detected in one (2%) case each (Table S4 ; see Supporting Information). In immunoblotting, two (20%) of 10 cases and two (29%) of seven cases showed positive IgG reactivity with RPs of the BP180 NC16a and C-terminal domains, respectively (Table S4 ; see Supporting Information), while no reactivity was found for any protein in normal human dermal extracts, concentrated culture supernatant of HaCaT cells or purified human laminin-332 (Table S4 ; see Supporting Information).
Enzyme-linked immunosorbent assays
In commercially available ELISAs for BP180 and BP230, three (18%) of 17 examined cases showed IgG reactivity with BP180, four (36%) of 11 examined cases showed IgG reactivity with BP230, and one each of two cases showed IgA reactivity with BP180 and BP230 (Table 3) . In commercially available ELISAs for Dsg1 and Dsg3, they reacted with IgA antibodies in six (16%) each of 38 examined cases (Table 3 ). In contrast, only very low titres of IgG antibodies to Dsg1 and Dsg3 were detected, in one (3%) each of 39 cases. Thus, four cases with IgA antibodies to Dsg1 were diagnosed as IgA-PF, and the six cases with IgA antibodies to Dsg3 with or without IgA anti-Dsg1 antibodies were diagnosed as IgA-PV.
In novel ELISAs of mammalian RPs of human Dsc1-3 for 41 cases of IAD, IgA antibodies reacted with Dsc1 (15 cases, 37%), Dsc2 (seven, 17%) and Dsc3 (five, 12%), while none of 10 cases of IAD examined showed IgG reactivity with any of Dsc1-3 (Table 3) .
Regarding more specific IgA reactivity, among 16 cases of the SPD type examined, 11 (69%) reacted with Dsc1, while none reacted with Dsc2 and one (6%) reacted weakly with Dsc3 (data not shown). Only one of 11 IEN-type cases reacted solely with Dsc3. Only one of two cases of IgA-PVeg reacted solely with Dsc3. Two, one and one of three cases of IgA-PF; one, one and one of four cases of IgA-PV; and one, three and one of seven unclassified IAD cases reacted with Dsc1, Dsc2 and Dsc3, respectively.
COS-7 cell cDNA transfection
In COS-7 cell cDNA transfection experiments on 46 cases of IAD, 10 (22%), including eight SPD-type cases, showed IgA reactivity exclusively with Dsc1 (Table 3) . Three cases showed very weak IgG reactivity with both Dsc1 and Dsc3.
Clinical findings in 13 cases of classical subcorneal pustular dermatosis
Background of cases
The 13 cases of classical SPDs included 12 Japanese and one Australian patient. At the time of consultation to us, classical SPD, IAD and PF were suspected in nine, two and two cases, respectively, while one case was suspected to be either dermatitis herpetiformis or linear IgA bullous dermatosis. For the 13 cases of classical SPD, most IF, immunoblotting and ELISA studies were performed, but showed no positive results.
There were four male and seven female patients, with two cases without sex information. The mean age at disease onset of 12 cases was 75Á6 years (male, 84Á6 years; female, 66Á5 years). The durations of disease before our tests ranged from 1 month to 20 years (mean 45Á7 months).
Before visiting the practitioners, the cases were treated with dapsone (two cases) and aciclovir (one case). There were no other specific underlying diseases.
Clinical and histopathological manifestations and therapies
The 13 cases of classical SPD were reported to develop skin lesions on the whole body (one case), trunk (eight), extremities (six) and intertriginous areas (four), with frequent involvement of the lower extremities (five) and axillae (three) ( Table S5 ; see Supporting Information). One case each had oral and nasal mucosal lesions. Clinical features were pustules (seven cases), blisters (six), erythemas (seven) and erosion (three) ( Table S5; see Supporting Information). Two cases reported itch.
All 11 cases examined histopathologically presented subcorneal pustules, and intraepidermal infiltrations of neutrophils and eosinophils were found in nine and three cases, respectively (Table S5 ; see Supporting Information). One case showed acantholysis.
Dapsone was effective in one case, but not in one case (Table S5 ; see Supporting Information). Systemic steroids were ineffective in two cases.
Discussion
Although the diagnosis of IAD is first suspected by clinical and histopathological features, various immunological examinations are necessary to make definite diagnoses of IAD and its subtypes. In this study, most of our routine immunoserological tests described above, [1] [2] [3] as well as newly developed mammalian Dsc ELISAs and Dsc cDNA transfection, were performed in the 49 cases of IAD and 13 cases of classical SPD in various combinations. In this study, by our tentative diagnostic criteria for IAD, we selected 49 cases of IAD, and classified them into five subtypes (Table 1 ). In addition, our biological tests showed concurrence of other AIBDs in a few cases. We also selected 13 cases of classical SPD. Clinical assessment for the 49 cases of IAD revealed an equal male-to-female ratio. The mean age at disease onset of 45Á9 years was much lower than in other AIBDs. It was characteristic that six cases of IAD, and no SPD-type cases, showed ulcerative colitis, and that IgA with multiple myeloma and elevated serum IgA levels were found in one and three cases, respectively. Thus, IAD may develop on an abnormal immunological background. In contrast, internal malignancies were rarely found.
Clinically, most cases showed pustular and bullous lesions with erythemas on various sites, particularly in intertriginous areas in the SPD-type. The most common manifestations were blisters, pustules and erythemas, with an annular pattern in some cases. Mucosal lesions were rarely seen. The histopathological findings were compatible with those in previous reports. 4, 5 Regarding treatments, dapsone and systemic steroids were used in 11 and 10 cases, respectively, with or without benefits. Minocycline was also effective.
Concerning the immunological studies, the combination of direct IF, IgA indirect IF of normal human skin and IgA ELISAs of Dsg1/Dsg3 and Dsc1-3 was valuable in the diagnosis of IAD. Although the IgA cDNA transfection could detect IgA anti-Dsc1 antibodies, IgA Dsc ELISAs were considered to be superior, because of difficulty in the procedure and assessment in cDNA transfection. The sensitivity of IgA immunoblotting of normal human epidermal extract was very low.
No case of classical SPD showed positive immunological results. The age at disease onset was much higher than in IAD, particularly in male cases. Because the clinicopathological features were indistinguishable from those in SPD-type IAD, the differential diagnosis between the two diseases was difficult without immunological results.
In conclusion, this study has the largest cohort of cases of IAD reported to date. We propose a classification of IAD into five subtypes, and we frequently detected IgA antibodies to Dsgs and Dscs.
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